http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-944476-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 1994-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f8cc5442ad3ffd991f12370b737bbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc045e2eafbac20ae779dc976d711bd0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8da082017b8a94d433e3d08ca7b6e56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c91866911a769798a8078c38b9ee0f1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7345344d441ab7d67b51d833b787aec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee20d008cf8f9d14620652c67ab0c159 |
| publicationDate | 1994-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NO-944476-L |
| titleOfInvention | Tetrahydro- and perhydro-isoquinoline derivatives and therapeutic agents containing them |
| abstract | Oral use drug, which acts as an active ingredient in addition to the usual galenic aids. single dose contains 10 to 1,000 mg of a compound of the general formula I or II NWR2 NWR2 wherein: W means a carbonyl group or a single bond; R1 is a hydrogen atom or group of the general formula R3CO wherein R3 represents a lower alkyl, lower alkoxy, monolaverealkylamino or dilaveralkylamino group; R2 an alkyl residue having 3 to 20 carbon atoms branched or straight chain, containing 1 to 3 double bonds, may contain a saturated cycle of 3 to 7 carbon atoms integrated into the chain, or as a substituent, may be substituted by one or more aromatic rings or contain an oxygen or sulfur atom, such as racemates as well as isolated enantiomers, or their addition salt with a physiologically tolerable acid, as well as the active substances themselves, to the extent that they are new. |
| priorityDate | 1992-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.